06:39 AM EDT, 03/26/2024 (MT Newswires) -- Ampio Pharmaceuticals ( AMPE ) said late on Monday that its board voluntarily decided to delist its common stock from the NYSE American.

The company said the board based its decision on factors such as the current and likely future non-compliance with listing requirements that would inevitably result in delisting.

The board also considered the required personnel resources and costs relating to disclosure and reporting requirements and related regulatory burdens, which have resulted and would continue to result in significant operating expenses.

Shares of the company sank 35% in premarket activity Tuesday.

Price: 1.1, Change: -0.58, Percent Change: -34.52